Azithromycin Tablets recalled over manufacturing violations
- Recall date
- April 22, 2015
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- Wockhardt Usa Inc. recalls Azithromycin Tablets, USP, 250 mg Tablets, Packaged in A) 30 Count Bottles (NDC: 64679-0961-01), B) 3,500 Count Pouches…
- Recall number
- D-1248-2015
- FDA classification
- Class II
- Brand / firm
- Wockhardt Usa Inc.
- Sold / distributed
- U.S. Nationwide including Puerto Rico.
Why it was recalled
CGMP Deviations: Firm did not adequately investigate customer complaints.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Azithromycin Tablets, USP, 250 mg Tablets, Packaged in A) 30 Count Bottles (NDC: 64679-0961-01), B) 3,500 Count Pouches (NDC: 64679-961-08), and C) 3 x 6 Tablet Card Cartons (NDC: 64679-961-05), Rx only. Manufactured by: Wockhardt Limited, Mumbai, India. Distributed by: Wockhardt USA LLC 20 Waterview Blvd. Parsippany, NJ 07054 USA.
Get recall alerts
Free email alert whenever Wockhardt Usa Inc. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Wockhardt Usa Inc.